CapEx at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's capex?
- Jazz Pharmaceuticals (JAZZ) reported capex of $19.7M in Q1 2026.
- How has Jazz Pharmaceuticals's capex changed year-over-year?
- Jazz Pharmaceuticals's capex increased by 41.7% year-over-year, from $13.9M to $19.7M.
- What is the long-term trend for Jazz Pharmaceuticals's capex?
- Over 3 years (2021 to 2025), Jazz Pharmaceuticals's capex has grown at a 28.6% compound annual growth rate (CAGR), from $27.64M to $58.75M.
- What does capex mean?
- Cash spent on physical assets like buildings and equipment.
- How do you interpret capex?
- Higher spending indicates infrastructure expansion or modernization, while lower spending may suggest efficient asset utilization or deferred maintenance.
- How does capex compare across companies?
- Standard across all industries; high for manufacturing, low for software/services.